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ABSTRACT
Although inhibition of p16INK4a expression is critical to preserve the proliferative capacity of
stem cells, the molecular mechanisms responsible for silencing p16INK4a expression remain
poorly characterized. Here, we show that the histone acetyltransferase (HAT) monocytic leuke-
mia zinc finger protein (MOZ) controls the proliferation of both hematopoietic and neural stem
cells by modulating the transcriptional repression of p16INK4a. In the absence of the HAT activity
of MOZ, expression of p16INK4a is upregulated in progenitor and stem cells, inducing an early
entrance into replicative senescence. Genetic deletion of p16INK4a reverses the proliferative
defect in both MozHAT2/2 hematopoietic and neural progenitors. Our results suggest a critical
requirement for MOZ HAT activity to silence p16INK4a expression and to protect stem cells from
early entrance into replicative senescence. STEM CELLS 2014;32:1591–1601
INTRODUCTION
Self-renewal of stem cells is vital for maintain-
ing tissues homeostasis throughout the life
span of an organism. Because of their high-
mitotic activity, stem cells have to put in place
inherent cellular defense mechanisms, such as
senescence and apoptosis, to avoid the expan-
sion of potentially malignant cells resulting
from the accumulation of oncogenic muta-
tions. Cells undergoing senescence display dra-
matic changes in chromatin structure, which
contribute to the irreversible nature of the
senescent state. These changes are regulated
by the activities of chromatin modifying
enzymes; however, the nature of these specific
enzymes and their role in the control of senes-
cence remains mostly unknown.
The histone acetyltranferase monocytic
leukemia zinc finger protein (MOZ; MYST3 or
KAT6A) is a key regulator of hematopoiesis
recurrently found translocated in acute mye-
loid leukemia [1–5]. Both MOZ null mouse
embryos and mice carrying a G657E mutation,
which renders the protein catalytically inactive
(MozHAT2/2 hereafter), have severe defects in
the generation and maintenance of hemato-
poietic stem cells (HSCs) [6–8]. In the absence
of MOZ histone acetyltransferase (HAT) activ-
ity, the proliferative capacity of hematopoietic
progenitors is dramatically impaired, with
many cells withdrawing from the cell cycle
during the G1 phase [8].
In this study, we establish that the prolifer-
ative defect observed in the absence of the
HAT activity of MOZ is not limited to the
hematopoietic compartment, but also extends
to neural stem cells and progenitors (NSC/Ps).
We show that this proliferative defect is
caused by the upregulation of p16INK4a expres-
sion leading to a premature entry into replica-
tive senescence and that the senescent
phenotype can be rescued by genetic deletion
of p16INK4a. We further demonstrate that MOZ
binds directly to the promoter of p16INK4a indi-
cating that this tumor suppressor is a direct
target of MOZ. Our findings suggest that these
two stem cell types, HSCs and NSCs, use the
same novel mechanism involving MOZ-driven
acetylation to maintain their capacity to prolif-
erate and avoid senescence. Altogether, these
results provide new insights into the control of
stem and progenitor cell proliferation and
identify an unexpected role of MOZ-mediated
acetylation in the regulation of p16INK4a
expression. This finding also suggests that a
potential reinforcement of the repressive activ-
ity of MOZ on p16INK4a expression could be an
important mechanism supporting the develop-
ment of acute myeloid leukemia following
MOZ translocations.
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TISSUE-SPECIFIC STEM CELLS
MATERIALS AND METHODS
Cell Culture and Growth Curves
Differentiation of embryonic stem cells (ESCs) into embryoid
bodies (EBs) was carried out as described previously [8, 9].
Serum-free conditions that sustain the proliferation of hema-
topoietic precursors in liquid culture were described previ-
ously [10]. For neurospheres culture, we used the “NeuroCult
Proliferation Kit” (Stem Cell Technologies, www.stemcell.com).
To test the self-renewal capacity of neurospheres, cells were
isolated from primary spheres using a NeuroCult Chemical
Dissociation Kit (Stem Cell Technologies, www.stemcell.com).
Self-renewal was quantified as number of secondary neuro-
spheres generated per primary neurosphere. For proliferation
studies, 10 mM 5-bromo-2-deoxyuridine (BrdU) was added to
the cultures for 12 hours at 37C.
Expression Analysis
Total RNA was extracted with an RNAeasy kit, treated with
RNAse-free DNase (QIAGEN, www.qiagen.com), and reverse-
transcribed into cDNA with random hexamers by use of an
Omniscript RT kit (QIAGEN, www.qiagen.com). Real-time poly-
merase chain reaction (PCR) was performed on an ABI 7900
system (Applied Biosystems, www.lifetechnologies.com) using
the Exiqon universal probe library and primer designer
(Roche, www.roche.com). All expression data were calculated
relative to b-actin as 22Dct. Data are presented as DCt values
from triplicates normalized to b-actin. Primer sequences are
available upon request.
Flow Cytometry
EBs were trypsinized (TryplE; Life technologies, www.lifetechnolo-
gies.com) for 3 minutes. Bone marrow of transplanted NOD Scid
Gamma NSG mice was isolated by flushing the femurs with
phosphate-buffered saline containing 2% fetal bovine serum. Single-
cell suspensions were analyzed on a FACScan or a FACScalibur flow
cytometer (Becton Dickinson, www.bd.com) or sorted on a FACS
Vantage cell sorter (Becton Dickinson). The antibodies used were as
follows: Mac1 (biotinylated), Sca-1 labelled with fluorescein isothio-
cyanate (FITC), and c-Kit (APC) were used for the HSC analysis; For
the isolation of Lin2cKit2 or CD45.21Lin2cKit1 population from
bone marrow, we used CD45.2 (Biotin) and cKit labelled with allo-
phycocyanin (APC) antibody together with a mix of antibodies rec-
ognizing lineage specific antigens Gr1, Mac1, B220, CD3, and Ter119
(PE). Staining with CD34 (Biotin) and cKit (APC) was performed to
isolate hematopoietic progenitors from day 6 EBs. For the isolation
of HSCs, we also included a combination of antibodies recognizing
members of the SLAM markers CD150 (PE), CD48 (APC), and
CD224.2 (FITC). All the antibodies were from BD Pharmingen or
ebiosciences. For cell cycle analysis, BrdU incorporation (BrdU Flow
kit, BD Pharmingen, www.bdbiosciences.com) was performed
according to the manufacturer’s instructions.
Senescence Analysis
Senescence associated b-galactosidase (SA b-gal) assay was
performed using a senescence b-galactosidase staining kit
(Cell Signaling, www.cellsingal.com).
Fetal Liver Transplantation and 5FU Treatment
NSG recipients (CD45.1) of 8- to 12-week-old were lethally
irradiated with 250cGy in two doses of 125 cGy 3 hours apart
and injected with donor (CD45.2) fetal liver cells. To deter-
mine the repopulating level of donor cells, peripheral blood
was collected and stained with anti-CD45.1 and anti-CD45.2.
For analysis of HSC proliferation in vivo, wild type (Wt) and
MOZ
HAT2/2 mice were intravenously administered 5-
fluorouracil (5FU; Mayne Pharma PLC, Warwick, UK) at a sin-
gle dose of 150 mg/kg body weight. Six days after 5-FU treat-
ment, bone marrow cells were isolated and analyzed for
p16
INK4a expression by immunostaining. Sorted 6-day 5FU cells
were grown in liquid culture in round-bottom microtiter
plates (10 cells per well). After 10 days of incubation, cell
number per well was scored using an inverted light
microscope.
Competitive Repopulation Assays
Experimental conditions for this assay were published previ-
ously [11]. Repopulating units (RUs) from each donor were cal-
culated according to the method described by Harrison and
Astle [12], where numbers of RUs are calculated from the per-
centage donor cells. In brief, the calculations are based in the
formula RU5%(C)/(1002%), where the number of fresh com-
petitor marrow cells used per 105 equals C and percentage cor-
responds to the obtained percentage of donor cells.
Transgenic Mice and Embryo Generation
All animal work was performed under regulations governed by
the Home Office Legislation under the Animal Scientific Proce-
dures Act of 1986. Ink4a1/2 mice were obtained from Dr. O.
Samson with the consent of Dr. M. Serrano.
ChIP Assays
Chromatin immunoprecipitation was performed using the Red
ChIP Kit (Diagenode, www.diagenode.com) following the instruc-
tions of the manufacturer. Crosslinked cells were sonicated for
15 cycles (30s on/30s off) with the Bioruptor (Diagenode,
www.diagenode.com). Antibodies used were RNA Polymerase
(H-224 from Santa Cruz Biotechnology, www.scbt.com) and anti-
HAT MYST3 antibody (Ab41718 from Abcam, www.abcam.com).
Ten million cells were used for each immunoprecipitation with
the anti-Moz antibody. Eluted chromatin was quantified by qual-
itative PCR (qPCR). Data for ChIP were obtained by subtracting
IgG control values to the corresponding antibody values. Graphs
represent fold increase over control IgG.
Immunoblotting and Immunocytochemistry
To analyze protein expression levels, cells were solubilized in
Radio-Immunoprecipitation Assay (RIPA) lysis buffer containing
a cocktail of protease inhibitors (Sigma Aldrich). Electrophore-
sis was carried out using commercial reagents (Novex; Life
Technologies, www.lifetechnologies.com). For immunoblot,
proteins were transferred to a nitrocellulose membrane using
the iBlot gel transfer apparatus (Life Technologies, www.life-
technologies.com). Nonspecific binding was blocked by incu-
bation in blocking buffer; Tris-buffered saline (TBST; 0.1%
Tween-20) containing 5% skimmed milk. After incubation with
the corresponding secondary antibodies, signal was developed
using the Enhanced Chemiluminescence Plus kit (ECL-Plus kit;
GE-Healthcare Bio-Sciences, www.gelifesciences.com). For
p16INK4a and HP1-c immunostainings cells were cytocentri-
fuged, fixed and stained with the corresponding antibody.
Antibodies used were HP1-c (07332 from Millipore,
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www.millipore.com) and p16INK4a (M-156 from Santa Cruz Bio-
technologies, www.scbt.com)
Statistics
Statistical comparisons of data sets were performed with the
two-tailed Student’s test.
RESULTS
HSC/Ps Undergo Early Entrance into Replicative
Senescence in the Absence of MOZ HAT Activity
We established previously that HSCs and blood precursors car-
rying the mutated G657E MOZ protein lacking HAT activity
have a profound proliferative deficiency, with many cells arrest-
ing in the G1 phase of the cell cycle [8]. A cell leaving the cell
cycle during the G1 phase may encounter different fates: it can
differentiate, become quiescent, senescent, or undergo apopto-
sis. No signs of increased apoptosis or defects in differentiation
were observed in MozHAT2/2 hematopoietic progenitors [8]
suggesting quiescence or senescence as the most likely fates.
Therefore, we evaluated whether the reported G1 arrest previ-
ously observed in MozHAT2/2 CD341cKit1 hematopoietic pro-
genitors is related to the acquisition of a senescent phenotype.
Consistent with this hypothesis, a higher frequency of cells pos-
itive for the presence of senescence-associated heterochroma-
tin foci (SAHF) [13], marking the accumulation of the nuclear
Heterochromatin Protein 1-gamma (HP1c) protein was detected
in MozHAT2/2 CD341cKit1 hematopoietic progenitors generated
by in vitro ESC differentiation than in their Wt counterparts
(Fig. 1A). A significantly higher percentage of the hematopoietic
progenitors also expressed the senescence-associated b-
galactosidase (SA b-gal) in the absence of the HAT activity of
MOZ (Fig. 1B). The progression through the G1 phase of the
cell cycle in stem cells has been shown to be controlled by dif-
ferent cyclin-dependent kinase (CDK) inhibitors, such as
p16(INK4a) [14–16], p21(CIP1) [16–20], p27 (Kip1) [21, 22], and
p57(Kip2) [23, 24]. We analyzed the transcription levels of
these CDK inhibitors to evaluate whether changes in their
expression could be linked to the observed phenotype in
MozHAT2/2 hematopoietic progenitors. Only transcriptional lev-
els of the tumor suppressor p16INK4a were significantly altered
in MozHAT2/2 cells (Fig. 1C). To further investigate whether this
upregulation of p16INK4a was reflecting changes in the tran-
scription levels of known regulators of this tumor suppressor,
such as Bmi1 [15, 25], Ezh1 [26], Ezh2 [27, 28], and Suz12 [29],
we analyzed the expression of these genes by qPCR. We found
no significant difference in the expression levels of proteins
known to control p16INK4a transcription (Fig. 1C). We then veri-
fied that the transcription levels of p16INK4a were rapidly upreg-
ulated in MozHAT2/2 hematopoietic progenitors upon culture
conditions that promote their proliferation (Fig. 1D). Higher lev-
els of p16INK4a protein were also detected in these cells by
immunoblotting and immunostaining (Fig. 1E, 1F). Similarly, to
the in vitro ESC-derived blood cells, MozHAT2/2 cells isolated
from embryonic fetal liver and highly enriched for HSCs
(Lin2Sca1cKit1CD1501CD482) [30] had a limited proliferative
capacity (Fig. 2A). This proliferative defect was reflected by a
significantly lower percentage of cells in the S-phase of the cell
cycle, and the accumulation of cells in the G1 phase as shown
by BrdU incorporation analysis (Fig. 2B). qPCR analysis also
revealed that MozHAT2/2 fetal liver HSCs displayed increased
expression levels of p16INK4a upon culture (Fig. 2C). To confirm
our findings with adult hematopoietic progenitors and circum-
vent the limiting perinatal lethality of MozHAT2/2 mice, we
transplanted Wt or MozHAT2/2 fetal liver cells (CD45.21) into
irradiated immunodeficient NSG (CD45.11) mice. Analyses of
peripheral blood chimerism in transplanted animals 4 weeks
after transplantation indicated that baselines of engraftment by
CD45.21 cells were higher than 90% and similar between mice
repopulated by either Wt or MozHAT2/2 fetal liver cells (Sup-
porting Information Fig. S1A). We then isolated adult
CD45.21Lin2cKit1 hematopoietic progenitors from the bone
marrow of the reconstituted mice for analysis. The MozHAT2/2
cells displayed again proliferative defects associated with an
increase in p16INK4a protein levels upon ex vivo culture in pro-
liferation media (Supporting Information Fig. S1B–S1F). To con-
firm these ex vivo findings and assess proliferation in vivo,
cohorts of reconstituted mice were treated with 5FU to induce
HSC entry into cell cycle [31, 32]. The p16INK4a protein was
detected by immunostaining in CD45.21Lin2cKit1 bone mar-
row cells isolated from 5FU treated MozHAT2/2 mice 6 days
after treatment (Fig. 2D), whereas no positive staining was
observed in 5FU-treated Wt controls. In addition, 7–10 days after
treatment, a high percentage of 5FU-treated mice reconstituted
with MozHAT2/2 had to be euthanized (Fig. 2E) due to excessive
weight loss (Supporting Information Fig. S1G) associated with the
development of low blood counts (Fig. 2F). These findings are
consistent with the profound long-term repopulation potential
defect of MozHAT2/2 HSCs in serial transplantation experiments
as documented previously [8]. Altogether, these experiments
demonstrate that the absence of the HAT activity of MOZ either
in ESCs derived, fetal or adult hematopoietic progenitors results
in cell autonomous proliferative defects triggered by a premature
entry into replicative senescence.
NSCs Self-Renewal Relies on MOZ HAT Dependent
Silencing of p16INK4a
MOZ and its close homologue MORF (MOZ related factor,
MYST4 or KAT6B) have been assigned specific roles in either
hematopoietic or neural development, respectively [33, 34].
However, our previous observation that MozHAT2/2 ESCs, unlike
their Wt counterparts, did not extensively contribute to the for-
mation of the brain in chimeric mice [8] suggests that MOZ,
through its HAT activity, might also play a role in regulating the
proliferation of NCS/Ps. To test this hypothesis, we first cultured
cells isolated from the telencephalon of Wt and MozHAT2/2
E14.5 embryos under clonogenic conditions to compare their
potential to generate self-renewing neurospheres, a measure-
ment of the number of cells with neural stem-like properties
[35, 36]. MozHAT2/2 embryos generated three times less neuro-
spheres than Wt controls (Fig. 3A) suggesting that there are sig-
nificantly fewer NSCs in the telencephalon of MozHAT2/2
embryos. In addition, MozHAT2/2 neurospheres displayed
reduced expansion kinetics, producing fewer neurospheres at
each passage, with an expansion index fivefold lower than Wt
neurospheres (Fig. 3B), suggesting a reduced self-renewal poten-
tial. In fact, no neurospheres could be generated from the
MOZHAT2/2 cells after the third passage. In addition to this
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reduced expansion rate, MozHAT2/2 neurospheres were, on
average, smaller than their Wt counterparts (Fig. 3C), which
could be indicative of cell-cycle arrest. BrdU incorporation analy-
sis of MozHAT2/2 secondary neurospheres revealed a reduced
percentage of cells in the S-phase of the cell cycle and accumula-
tion of cells at the G1 phase, similar to the phenotype observed
for MozHAT2/2 hematopoietic progenitors (Fig. 3D). Consistent
with the acquisition of a senescent phenotype, cells from sec-
ondary MozHAT2/2 neurospheres also displayed SA b-gal activity
and higher p16INK4a expression levels than Wt controls (Fig. 3E,
3F). These in vitro findings were further substantiated in vivo by
the observation that a lower percentage of cells expressing alde-
hyde dehydrogenase (ALDH), a marker of cells with stem-like
properties [37, 38], was detected in brains of E14.5 MozHAT2/2
Figure 1. MozHAT2/2 CD341cKit1 hematopoietic progenitors leave the cell cycle to undergo early entrance into replicative senescence.
(A): Senescence-associated heterochromatin foci. Wt and MozHAT2/2 CD341cKit1 hematopoietic progenitors isolated from day 6 embry-
oid bodies (EBs) were stained for Heterochromatin Protein 1-gamma (HP1-c) (green) and 4’,6-diamidino-2-phenylindole (DAPI) (blue)
(magnification 340). Bar graph indicates the percentage of cells stained positive for HP1-c after 8 days in proliferation media. Bars rep-
resent mean6 SEM (B): CD341cKit1 hematopoietic progenitors were stained with X-gal to detect the senescence-associated (SA) b-gal
activity (pH: 6). Pictures show one representative cell of each group (magnification 3100). Bar graph indicates the percentage of cells
stained after 10 days of culture in proliferation media. (C): Qualitative polymerase chain reaction (qPCR) analysis of the expression of
diverse cyclin-dependent kinase inhibitors and p16INK4a regulators in CD341cKit1 hematopoietic progenitors. For each gene, values for
the MozHAT2/2 are calculated relative to those of the Wt. Wt and MozHAT2/2 progenitors cells were directly isolated from day 6 EBs
and cultured in proliferation media for 48 hours before the analysis. Graph shows average values of three different experiments. Bars
represent mean6 SEM (D): qPCR analysis of p16INK4a transcripts levels in CD341cKit1 cells after 12 hours in proliferation media. (E):
Immuno-blot shows p16INK4a levels of CD341cKit1 hematopoietic progenitors 12 hours after plating in proliferation media. (F): Immuno-
staining of CD341cKit1 hematopoietic progenitors 12 hours after plating (magnification 320). Bar graph indicates the percentage of
positive cells for p16INK4a. Abbreviations: HAT, histone acetyltransferase; SA b-gal, senescence-associated b-galactosidase; SAHF,
senescence-associated heterochromatin foci; Wt, wild type.
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Figure 2. Impaired proliferation and p16INK4a upregulation in MozHAT2/2 hematopoietic stem cell (HSC)/Ps in vivo. (A): Individual HSCs
(Lin2Sca1cKit1CD1501CD482) isolated from the fetal liver of Wt and MozHAT2/2 embryos were sorted into 96-well plates containing
proliferation media. Cell number was scored after 10 days. (B): Cell cycle status of Lin2Sca1cKit1CD1501CD482 fetal liver cells isolated
from E14.5 embryos. Pregnant females were injected with 5-bromo-2-deoxyuridine 1 hour before harvesting of embryos and cell cycle
was analyzed by flow cytometry. (C): Qualitative polymerase chain reaction analysis of p16INK4a expression in
CD45.21Lin2Sca1cKit1CD1501CD482 cells isolated from the bone marrow of reconstituted mice after 24 hours of culture in prolifera-
tion media. (D): Reconstituted mice were treated with 5FU. Bone marrow was harvested 6 days later and CD45.21Lin2cKit1 cells were
immunostained with a p16INK4a antibody. MOZHAT2/2 bone marrow cells expressing p16INK4a are shown in the picture (magnification
340). No cells positive for the p16INK4 staining were detected in the bone marrow of Wt reconstituted mice (data not shown). (E):
Kaplan-Meier graph showing the survival of reconstituted NSG mice after 5FU injection. Control mice were not injected. Wt (n 5 6), Wt
5FU (n 5 6), histone acetyltransferase HAT2/2 (n 5 8) and HAT2/2 5FU (n 5 8). (F): Low white and red blood cell counts and reduced
bone marrow cellularity are detected in NSG mice reconstituted with MozHAT2/2 fetal liver cells 7 days after injection with 5FU. Abbrevi-
ations: HAT, histone acetyltransferase; HSC, hematopoietic stem cell; MOZ, monocytic leukemia zinc finger protein; NSG, NOD Scid
Gamma; Wt, wild type.
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embryos compared with Wt embryos (Fig. 4A). Furthermore, a
reduction in the number of cells expressing the proliferation
marker Ki67 (Fig. 4B) and cells incorporating BrdU (Fig. 4C) was
also observed in the brains of E14.5 MozHAT2/2 embryos. Finally,
qPCR analysis of E14.5 telencephalons revealed an increased
p16
INK4a expression in the telencephalon of MozHAT2/2 embryos
(Fig. 4D). Altogether, these data demonstrate that, similarly to
the hematopoietic system, MozHAT2/2 NSC/Ps display prolifera-
tive defects ex vivo and in vivo, upregulate the expression of
p16
INK4a and readily enter into replicative senescence.
Genetic Deletion of p16INK4a Largely Restores the
Proliferative Capacity of HSC/Ps and NSC/Ps
As p16INK4a upregulation could be exacerbated in culture, we
decided to directly evaluate to which extent the proliferative
defects observed in MozHAT2/2 mice are associated to an
entry into replicative senescence induced by p16INK4a upregu-
lation in vivo. To this end, we crossed heterozygote mice for
the HAT mutation with p16INK4a/p19ARF knockout mice (here-
after INK4a2/2) [39] to generate double-knockout mice as
well as heterozygotes and Wt control littermates. In the
absence of INK4a, the embryonic and perinatal lethality of
Moz
HAT2/2 mice was clearly diminished resulting in increased
frequency of MozHAT2/2 mice at weaning (Fig. 5A). In addi-
tion, in the absence of p16INK4a, MozHAT2/2 mice displayed an
overall improved health status and a recovery of the runt
phenotype reported previously for these mice [8]. We next
investigated whether the decreased frequency in HSC popula-
tion observed in the fetal liver of MozHAT2/2 embryos [8] was
restored to normal level by deletion of p16INK4. Indeed
INK4a
1/1/MozHAT2/2 (Wt/Ko) embryos displayed a reduced
percentage of HSCs (Lin2Sca1cKit1CD1501CD482), whereas
the frequency of these cells was significantly higher in
Moz
HAT2/2 mice lacking p16INK4a (Ko/Ko) reaching similar val-
ues to those detected in INK4a1/1/MozHAT1/1 (Wt/Wt)
embryos (Fig. 5B). To further investigate the contribution of
p16INK4a to the proliferative defects of MozHAT2/2 HSCs, we
evaluated the ability of MozHAT2/2 fetal liver cells on different
Figure 3. Telencephalon cells isolated from MozHAT2/2 embryos display marked proliferative defects and signs of replicative senes-
cence. (A): Frequency of primary neurospheres generated by E14.5 telencephalon cells. (B): Expansion index indicating the number of
secondary neurospheres generated per primary neurosphere. (C): Morphology of Wt and MozHAT2/2 day 8 tertiary neurospheres. Neuro-
spheres are classified in different groups based on the diameter of the sphere. (<0.1 mm, 0.1–0.2 mm, and >0.2 mm). Bars represent
mean6 SEM (n 5 4). (D): Cell-cycle status of cells in neurospheres. Cells were isolated from day 6 secondary neurospheres. Percentage
of cells in G1, S, and G2/M phases are indicated. Bars represent mean6 SEM (n 5 3). (E): Senescence-associated b-galactosidase activity
(pH: 6) in day 7 Wt and MozHAT2/2 primary neurospheres. Magnification (340). (F): Analysis of p16INK4a transcript levels in day 7 Wt,
and MozHAT2/2 neurospheres (n 5 4 for each genotype). Abbreviations: 7AAD, 7-Aminoactinomycin D; BrdU, 5-bromo-2-deoxyuridine;
HAT, histone acetyltransferase; SA b-gal, senescence-associated b-galactosidase; Wt, wild type.
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INK4a backgrounds to repopulate the bone marrow of lethally
irradiated recipients. INK4a1/1/MozHAT1/1 (Wt/Wt), INK4a2/2/
Moz
HAT1/1 (Ko/Wt), INK4a1/1/MozHAT2/2 (Wt/Ko) and
INK4a
2/2/MozHAT2/2 (Ko/Ko) E14.5 CD45.21 fetal liver cells
were transplanted into lethally irradiated congenic CD45.11
mice together with competitor CD45.11/CD45.21 cells.
INK4a
2/2/MozHAT2/2 (Ko/Ko) fetal liver cells showed a signifi-
cantly higher capacity to repopulate the bone marrow of recip-
ient mice than INK4a1/1/MozHAT2/2 (Wt/Ko) cells (Fig. 5C)
indicating that the defective self-renewal capacity of
Moz
HAT2/2 HSCs could be rescued, at least partially, by the
deletion of p16INK4a and strongly suggesting that p16INK4a is a
critical MOZ target for the maintenance of HSC self-renewal.
Similar to what we observed for the hematopoietic system, the
genetic deletion of p16INK4a resulted in higher numbers of pri-
mary neurospheres generated by telencephalon cells of E14.5
Moz
HAT2/2 embryos (Fig. 5D). Furthermore, serial passage of
these primary neurospheres produced numbers of tertiary neu-
rospheres similar of that of the Wt/Wt (Supporting Information
Fig. S2A), indicating a substantial recovery of the expansion
index of MozHAT2/2 neurospheres in the absence of INK4a
(Supporting Information Fig. S2B). Altogether, these results sug-
gest that the defects observed in these MozHAT2/2 neural cells
are also mediated by the upregulation of p16INK4a. These
results indicate that p16INK4a upregulation in MozHAT2/2 cells
inhibit NSC self-renewal driving cells into replicative senescence
in a similar fashion to HSC/Ps lacking MOZ HAT activity.
MOZ Binds to the Promoter of the p16INK4a Tumor
Suppressor
In the absence of significant changes in the expression levels of
known p16INK4a regulators, we decided to evaluate next by chro-
matin immunoprecipitation whether MOZ could directly bind to
the p16INK4a promoter. The use of hematopoietic progenitors for
these experiments would involve the isolation of very large num-
ber of cells difficult to obtain. To overcome this limitation, we
decided to check whether the senescent phenotype was con-
served in MozHAT2/2 mouse embryonic fibroblasts (MEFs), which
would provide a source of large numbers of cells needed for
this study. We observed in clonogenic assays that the number
of large proliferative colonies formed by individual MOZHAT2/2
MEFs was almost three times less than those formed by Wt
Figure 4. Impaired proliferation and p16INK4a upregulation in MozHAT2/2 neural stem cells and progenitors in vivo. (A): Flow cytometry
plots of ALDH activity in Wt and MozHAT2/2 telencephalon cells. Cells isolated from E14.5 telencephalons were incubated with the
ALDH substrate aldefluor in the presence or absence of the ALDH inhibitor diethylaminobenzaldehyde. Bar graph reflects the average
percentage of ALDH positive cells. (B): Coronal sections of Wt and MozHAT2/2 E14.5 telencephalons stained with anti-Ki67 antibody.
Scale bar5 0.2 mm. (C): Sections of Wt and MozHAT2/2 E14.5 telencephalons stained with anti-BrdU antibody. Bar graph represents the
percentage of cells stained with BrdU. (D): Analysis of p16INK4a transcript levels in telencephalon tissue (n 5 24) isolated from Wt and
MozHAT2/2 E14.5 embryos. Scale bar5 0.2 mm. Abbreviations: ALDH, aldehyde dehydrogenase; BrdU, 5-bromo-2-deoxyuridine; DEAB,
diethylaminobenzaldehyde; HAT, histone acetyltransferase; SSC, Side Scatter; Wt, wild type.
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Figure 5. Impaired proliferation of MozHAT2/2 hematopoietic stem cell (HSC), neural stem cell, and progenitors is rescued by genetic
deletion of p16INK4a. (A): Genotype segregation of live mice produced by intercrossing of heterozygotes mice for the p16INK4a/ARF and
MozHAT mutations (Ink4a1/2, MozHAT1/2). Numbers indicate the frequencies of the mice for each genotype. (B): Analysis of E14.5 fetal
liver HSCs frequencies in INK4a2/2MozHAT1/1 (Ko/Wt), INK4a1/1MozHAT1/1 (Wt/Wt), INK4a1/1MozHAT2/2 (Wt/Ko), and INK4a2/2
MozHAT2/2 (Ko/Ko) littermates. Fluorescence-activated cell sorting plots show the percentage of Lin2Sca1cKit1 CD1501CD482 cells of
representative individuals in each group. Bar graph represents the average percentage of Lin2Sca1cKit1 CD1501CD482 cells in each
phenotype. (C): Competitive repopulation assay of irradiated mice. Data are expressed as Repopulating units per 10e6 cells. (D): Bar
graph shows the size of the neurospheres formed by telencephalon cells isolated from INK4a1/1MozHAT1/1 (Wt/Wt), INK4a2/
2MozHAT1/1(Ko/Wt), INK4a1/1MozHAT2/2 (Wt/Ko), and INK4a2/2MozHAT2/2 (Ko/Ko) littermates. *p< .05; **p< .01. Abbreviations:
HSC, hematopoietic stem cell; Ko, knockout; MOZ, monocytic leukemia zinc finger protein; RU, repopulating unit; Wt, wild type.
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MEFs (Supporting Information Fig. S3A). Additionally, growth
curves and cell cycle analyses using BrdU revealed a significant
decline in the proliferation rate of the MozHAT2/2 population
over time (Supporting Information Fig. S3B) as well as a defect in
the progression into the S-phase of the cell cycle (Supporting
Information Fig. S3C). MozHAT2/2 MEFs at passage five showed a
high proportion of flattened cells containing SA-b-gal (Supporting
Information Fig. S3D) and qPCR analysis of p16INK4a expression
revealed that transcript levels were upregulated on average
threefold in MozHAT2/2 MEFs compared with Wt (Supporting
Information Fig. S3E). Accordingly, protein levels of p16INK4a were
clearly higher in MozHAT2/2 MEFs than in the Wt and heterozy-
gous MozHAT1/2 MEFs (Supporting Information Fig. S3F).
Together these results clearly indicate that the senescent pheno-
type mediated by the upregulation of p16INK4a was also observed
in MozHAT2/2 MEFs.
To determine whether the transcriptional upregulation of
p16
INK4a in the MozHAT2/2 cells could be mediated by direct
binding of MOZ to this locus, we performed ChIP analyses
using MEFs isolated from E13.5 embryos. We detected MOZ
binding to the p16INK4a promoter in Wt MEFs. This binding
was conserved in MozHAT2/2 MEFs indicating that the HAT
mutation has no impact on the ability of MOZ to bind to this
locus (Fig. 6A). A slightly higher binding frequency of MOZ to
Figure 6. Monocytic leukemia zinc finger protein (MOZ) binding to the p16INK4a promoter at Wt and MOZHAT2/2 Mouse embryonic
fibroblasts. (A): Upper panel depicts p16INK4a promoter, exons, and introns. Numbers indicate amplified regions. Lower panel shows the
ChIP analysis of MOZ binding at the p16INK4a promoter in Wt and MozHAT2/2 MEFs. Binding of RNA Polymerase II was used as a positive
control. Samples were prepared from passage 3 MEFs. The promoter of the CSF1R gene, not expressed in MEFs, was used as a negative
control. *p< .05; **p< .01. Abbreviations: MOZ, monocytic leukemia zinc finger protein; TSS, Transcription Start Site.
Figure 7. Monocytic leukemia zinc finger protein (MOZ) histone acetyltransferase (HAT) activity regulates the proliferation of different
types of stem cells. The histone acetyltrasferase activity of MOZ prevents entry into early replicative senescence by regulating the
expression of the tumor supperssor p16INK4a. In the absence of MOZ HAT activity, the levels of p16INK4a are significantly increased in
both hematopoietic and neural stem and progenitor cell compartments. These cells then leave the cell cycle to become senescent,
therefore resulting in severely impaired hematopoietic stem cells and neural stem cells self-renewal. Abbreviations: BM, bone marrow;
HAT, histone acetyltransferase; HSC, hematopoietic stem cell; MOZ, monocytic leukemia zinc finger protein; NSC, neural stem cell.
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the p16INK4a promoter in the absence of HAT activity was con-
sistently observed and might reflect a compensatory mecha-
nism. Altogether, these results indicate that MOZ directly
binds to the p16INK4a promoter. This might through acetylation
of histones or potentially other interacting proteins, repress
the transcription of this locus.
DISCUSSION
In this study, we establish that in the absence of the HAT activ-
ity of MOZ HSC/Ps readily exit the cell cycle to undergo prema-
ture entry into replicative senescence. These findings provide a
likely explanation for the reported impairment of HSC self-
renewal observed in mice expressing the catalytically inactive
version of MOZ [8]. In contrast to previous studies restricting
the critical functions of MOZ and its close homologue MORF to
hematopoietic and NSCs, respectively [34], we demonstrate
here that similar proliferative defects are found in NSC/Ps lack-
ing MOZ HAT activity (model in Fig. 7). Our data reveal that this
common phenotype is at least partially caused by a premature
upregulation of p16INK4a expression. Accordingly, genetic dele-
tion of p16INK4a rescues to a large extent the proliferative
defect. The fact that this phenotype is shared between the
hematopoietic and neural compartments suggests that MOZ
controls a regulatory mechanism conserved among stem cells
from different tissues. This notion is supported by previous
results showing that the contribution to specific organs in chi-
meric mice was consistently lower with MozHAT2/2 ESCs than
with Wt ESCs. The tissues with different contributions also
included gut and liver in addition to the brain and hematopoi-
etic organs [8].
The hematopoietic and neuronal phenotype of the
Moz
HAT2/2 mice bear strong similarities with the proliferative
defects and premature senescence observed in neuronal and
hematopoietic cells in the Bmi1 knock out animals [25, 36, 40–
43]. Bmi1 and other polycomb members are well-established
negative epigenetic regulators of p16INK4a [44] whereas thri-
torax proteins [45] and SWI/SNF proteins [46] act positively on
its expression. We did not detect a significant change in the
level of expression of the p16INK4a regulators analyzed. How-
ever, we observed a direct interaction of MOZ to p16INK4a pro-
moter suggesting that MOZ could introduce changes in histone
acetylation pattern which, in turn, could alter the binding of
transcriptional regulators of p16INK4a harboring bromodomains.
Further studies will be required to determine whether the HAT
activity of MOZ directly impacts on the binding of regulators of
p16
INK4a expression or whether MOZ is implicated in a com-
pletely novel level of regulation. The INK4a locus is one of the
genomic regions most commonly mutated, deleted or epigeneti-
cally silenced in human cancers [47, 48]. It has been proposed
that the fusion proteins produced upon translocation of the
human MOZ locus with other HAT-encoding genes, such as CBP
or p300, support the development of leukemia by altering the
regulation of MOZ transcriptional targets. It would be interest-
ing to examine if the repressive activity on p16INK4a expression
mediated by MOZ acetylation is further exacerbated in these
fusion proteins. As such, these MOZ leukemic fusion proteins
might inhibit the triggering of senescence and promote the
development of leukemia [49]. Our findings also raise the
intriguing possibility that the regulation of p16INK4a expression
by MOZ could be used as a molecular target to induce senes-
cence in cancer stem cells.
CONCLUSION
The histone acetyltranferase MOZ (Monocytic Leukemia Zinc
Finger protein, MYST3, or KAT6A) has a crucial role in control-
ling hematopoietic stem cells (HSCs) proliferation. In this
study, we identified a critical requirement for MOZ-HAT activ-
ity to silence p16Ink4a expression, to avoid senescence and
sustain self-renewal of hematopoietic stem cells. We estab-
lished that this effect is not limited to the hematopoietic
compartment, but extends to neural stem cells and progeni-
tors (NSC/P) suggesting that these two types of cells, HSCs
and NSCs use the same mechanism involving MOZ-driven
acetylation in order to maintain their capacity to proliferate.
We propose that this mechanism could be also be critical for
the self renewal of other types of stem cells.
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